WordNet

visible; "be sure of it; give me the ocular proof"- Shakespeare; "a visual presentation"; "a visual image" (同)visual
of or relating to or resembling the eye; "ocular muscles"; "an ocular organ"; "ocular diseases"; "the optic (or optical) axis of the eye"; "an ocular spot is a pigmented organ or part believed to be sensitive to light" (同)optic, optical, opthalmic
relating to or using sight; "ocular inspection"; "an optical illusion"; "visual powers"; "visual navigation" (同)optic, optical, visual
the science or study of drugs: their preparation and properties and uses and effects (同)pharmacological medicine, materia_medica

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. シクロスポリンおよびタクロリムスの薬理作用および副作用 pharmacology and side effects of cyclosporine and tacrolimus
2. 抗てんかん剤の薬理学 pharmacology of antiepileptic drugs
3. 瘢痕性眼類天疱瘡 ocular cicatricial pemphigoid
4. 三環系抗うつ剤および四環系抗うつ剤：薬理学、投与、および副作用 tricyclic and tetracyclic drugs pharmacology administration and side effects
5. 眼性酒さ ocular rosacea

Physicochemical characterization and toxicological evaluation of plant-based anionic polymers and their nanoparticulated system for ocular delivery.

Pathak D1, Kumar P, Kuppusamy G, Gupta A, Kamble B, Wadhwani A.
Nanotoxicology.Nanotoxicology.2014 Dec;8(8):843-55. doi: 10.3109/17435390.2013.834996. Epub 2013 Sep 18.
The water-soluble fractions of mucilages and gum from the seeds of fenugreek, isphagula and mango bark exudate were isolated, purified and characterized using X-ray diffraction (XRD) spectrometry, Fourier transform infrared spectroscopy (FT-IR), maldi/GC-MS, elemental analysis, 1D ((1)H and (13)C) a
PMID 23952497

Tissue kallikrein (kallidinogenase) protects against retinal ischemic damage in mice.

Masuda T1, Shimazawa M1, Ishizuka F1, Nakamura S1, Tsuruma K1, Hara H2.
European journal of pharmacology.Eur J Pharmacol.2014 Sep 5;738:74-82. doi: 10.1016/j.ejphar.2014.05.033. Epub 2014 May 27.
Ocular ischemic syndrome is likely stem from retinal ischemia, and which causes visual disorder. The pathological mechanism of ocular ischemic syndrome is still unknown, therefore the optimal treatment for ocular ischemic syndrome remains to be established. Then, this study aimed to evaluate the eff
PMID 24877690

Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.

Hasan AA.
Pharmaceutical development and technology.Pharm Dev Technol.2014 Sep;19(6):748-54. doi: 10.3109/10837450.2013.829095. Epub 2013 Aug 22.
The objective of this work was to formulate and characterize non-ionic surfactant vesicles (niosomes) as an ocular carrier of dorzolamide hydrochloride (Dorzo); one of the antiglaucoma drugs. Niosomes were prepared of Cholesterol (Chol) with sorbitan monoesters (Span 20, 40, 60) or sorbitan trioleat
PMID 23964893

Neuroprotective Effect of Ocular Hypotensive Drugs: Latanoprost/Timolol in Combination Are More Effective than Each as Monotherapy in RGC-5

Vasodilator Effects of Elcatonin, a Synthetic Eel Calcitonin, on Retinal Blood Vessels in Rats

Comparison of Corneal Safety and Intraocular Pressure–Lowering Effect of Tafluprost Ophthalmic Solution with Other Prostaglandin Ophthalmic Solutions